Jason E. Shpilsky, MD

Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Cherry Hill
View 2 additional locations
Make an appointmentCall 800-789-7366
Headshot of Jason E. Shpilsky, MD
Penn Medicine Provider

About me

  • Clinical Assistant Professor of Medicine (Hematology-Oncology)

My education and training

  • Medical School: Temple University
  • Residency: Beth Israel Deaconess Medical Center
  • Fellowship: Beth Israel Deaconess Medical Center

Spoken languages

English
English

Reviews

Average Rating

1203 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
he answered all our questions.
Anonymous
May 2026
very knowledgeable, personable
Anonymous
May 2026
it was great
Anonymous
May 2026
excellent job!

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Shpilsky is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

Research

Publications

Demissei BG, Ko K, Huang A, Lee DJ, Doucette AG, Smith AM, Wilcox NS, Reibel J, Sun L, Agarwal M, Haas NB, Hollis G, Shpilsky JE, Takvorian SU, Vaughn DJ, Chen J, Hubbard RA, Powell-Wiley T, Yancy C, Narayan V, Ky B. Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer , JACC CardioOncol, 6(3): 2024,390-401

Roberts DA, Faig J, Bodio-Downey K, Shpilsky J, Leahy K, Wischhusen J, Giordano S, Acharya U, Drews R, Dougherty D, Lathan C, Rangachari D. Training Hematologists/Oncologists for the Academic-Community Hybrid: Creating a Fellowship Framework for the Future , JCO Oncol Pract, 19(6): 2023,e927-e934.

Shpilsky J, Stevens J, Bubley G. An up-to-date evaluation of abiraterone for the treatment of prostate cancer , Expert Opin Pharmacother, 22(10): 2021,1227-1234.

Rakowsky S, Flashner BM, Doolin J, Reese Z, Shpilsky J, Yang S, Smith CC, Graham K. Five Questions for Residency Leadership in the Time of COVID-19: Reflections of Chief Medical Residents From an Internal Medicine Program , Acad Med, 95(8): 2020,1152-1154

Rangachari D, To C, Shpilsky JE, VanderLaan PA, Kobayashi SS, Mushajiang M, Lau CJ, Paweletz CP, Oxnard GR, Jänne PA, Costa DB. EGFR-Mutated Lung Cancers Resistant to Osimertinib through EGFR C797S Respond to First-Generation Reversible EGFR Inhibitors but Eventually Acquire EGFR T790M/C797S in Preclinical Models and Clinical Samples , J Thorac Oncol, 14(11): 2019,1995-2002